| Thu, Nov 5, 2009 | | • | TapImmune Signs License Agreement With Crucell N.V.
GlobeNewswire (Thu, Nov 5)
| | • | Crucell N.V. upgraded by UBS
Briefing.com (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | • | Johnson & Johnson to cut up to 8,200 jobs
at MarketWatch (Tue, Nov 3)
| | • | Crucell 3Q profit falls 22 percent
AP (Tue, Nov 3)
| | • | Crucell Earnings Presentation Call scheduled for 8:00 am ET today
CCBN (Tue, Nov 3)
| | • | Q3 2009 Crucell Earnings Release - 01:45 am ET
CCBN (Tue, Nov 3)
| | • | Calmune and Crucell Enter Exclusive Research Collaboration
Marketwire (Tue, Nov 3)
| | • | UPDATE - Crucell Q3 profit falls 22 pct, keeps outlook
at Reuters (Tue, Nov 3)
| | • | Crucell Announces Third Quarter 2009 Results
Marketwire (Tue, Nov 3)
| | Wed, Oct 28, 2009 | | • | 2 Stocks Hitting Low Notes
at Motley Fool (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | • | Crucell to Release Q3 2009 Results on Tuesday November 3, 2009
Marketwire (Tue, Oct 27)
| | Wed, Oct 21, 2009 | | • | Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
Marketwire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference
Marketwire (Tue, Oct 20)
| | Fri, Oct 16, 2009 | | • | Baxter Beats Again -- the Streak Is Alive!
at Motley Fool (Fri, Oct 16)
| | Tue, Oct 13, 2009 | | • | J&J Needs to Get Drugged Up
at Motley Fool (Tue, Oct 13)
| | • | [$$] J&J Is Still OK
at Barrons.com (Tue, Oct 13)
| | • | J&J reports 1% profit rise despite lower sales
at MarketWatch (Tue, Oct 13)
| | • | J&J reports higher earnings, despite lower sales
at MarketWatch (Tue, Oct 13)
| | • | J&J reports moderately higher earnings
at MarketWatch (Tue, Oct 13)
| | Mon, Oct 12, 2009 | | • | [$$] JNJ Preview: Medical Devices Should Be the Highlight
at RealMoney by TheStreet.com (Mon, Oct 12)
|
Add CRXL News to My Yahoo!:
 
| |
|
0.12% Nasdaq 
0.24%
Headlines
